BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19375924)

  • 61. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
    Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).
    Dagrosa MA; Viaggi M; Rebagliati RJ; Castillo VA; Batistoni D; Cabrini RL; Castiglia S; Juvenal GJ; Pisarev MA
    Appl Radiat Isot; 2004 Nov; 61(5):911-5. PubMed ID: 15308167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
    Andoh T; Fujimoto T; Sudo T; Suzuki M; Sakurai Y; Sakuma T; Moritake H; Sugimoto T; Takeuchi T; Sonobe H; Epstein AL; Fukumori Y; Ono K; Ichikawa H
    Appl Radiat Isot; 2014 Jun; 88():59-63. PubMed ID: 24389062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7).
    Barth RF; Yang W; Bartus RT; Moeschberger ML; Goodman JH
    Neurosurgery; 1999 Feb; 44(2):351-9; discussion 359-60. PubMed ID: 9932889
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
    Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
    Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.
    Fujimoto T; Andoh T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Sonobe H; Epstein AL; Akisue T; Kirihata M; Kurosaka M; Fukumori Y; Ichikawa H
    Appl Radiat Isot; 2011 Dec; 69(12):1713-6. PubMed ID: 21354804
    [TBL] [Abstract][Full Text] [Related]  

  • 69. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
    Dagrosa MA; Crivello M; Perona M; Thorp S; Santa Cruz GA; Pozzi E; Casal M; Thomasz L; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):262-8. PubMed ID: 20932650
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
    Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
    Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
    Joel DD; Coderre JA; Micca PL; Nawrocky MM
    J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
    Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
    Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
    Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
    Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
    Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
    Papaspyrou M; Feinendegen LE; Müller-Gärtner HW
    Cancer Res; 1994 Dec; 54(24):6311-4. PubMed ID: 7987818
    [TBL] [Abstract][Full Text] [Related]  

  • 77. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.
    Detta A; Cruickshank GS
    Cancer Res; 2009 Mar; 69(5):2126-32. PubMed ID: 19244126
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy.
    Ishiwata K; Ido T; Mejia AA; Ichihashi M; Mishima Y
    Int J Rad Appl Instrum A; 1991; 42(4):325-8. PubMed ID: 1850716
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.
    Andoh T; Fujimoto T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Kawabata S; Kirihata M; Akisue T; Yayama K; Kurosaka M; Miyatake S; Fukumori Y; Ichikawa H
    Appl Radiat Isot; 2011 Dec; 69(12):1721-4. PubMed ID: 21367607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early effects of boron neutron capture therapy on rat glioma models.
    Nakagawa N; Akai F; Fukawa N; Fujita Y; Suzuki M; Ono K; Taneda M
    Brain Tumor Pathol; 2007; 24(1):7-13. PubMed ID: 18095138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.